7th Microbiome Movement - Human Nutrition Summit

As nutritional organizations seek to differentiate their products through modulation of the human microbiome, and further demonstrate the benefits of their products for improved human health, the 7th Microbiome Movement - Human Nutrition Summit remains the only industry meeting dedicated to moving the needle on scientifically validated, microbiome modulating, nutritional product development.

While the human microbiome continues to prove itself as an untapped source of scientific innovation for the nutritional community, there remain significant scientific challenges when translating microbiome R and D into safe, effective, and commercially scalable consumer health products.

If you're committed to developing pre-, pro-, or post-biotics, functional food, microbiome modulating ingredients, or other interventions that provide microbial-mediated health benefits, don't miss this year's only opportunity to tap into a unique network of peers who continue to solve some of the greatest scientific and product development challenges when harnessing the power of the gut microbiome.

With over 100+ human nutrition leaders uniting this November, the 7th Microbiome Movement - Human Nutrition Summit offers an unrivalled opportunity to optimize your product development and consumer acceptance of microbiome-based food and nutritional products.


URLs:
Website: https://go.evvnt.com/1854150-0?pid=10018
Tickets: https://go.evvnt.com/1854150-2?pid=10018
Brochure: https://go.evvnt.com/1854150-3?pid=10018

Prices:
Drug Developer - Conference + Post-Conference Workshop Day: USD 3098.00,
Drug Developer - Conference Only: USD 2099.00,
Academic and Not for Profit - Conference + Post-Conference Workshop Day: USD 2598.00,
Academic and Not for Profit - Conference Only: USD 1999.00,
Solution and Service Provider - Conference + Post-Conference Workshop Day: USD 5098.00,
Solution and Service Provider - Conference Only: USD 3799.00

Speakers: Anastasia Gutkevich, Chief Executive Officer, Bifidice, Anders Brimnes, Damholt Head of Clinical Development, Chr. Hansen, Beth Statkus, Founder, Sorridi, Christopher Warner, Director of R and D, Proliant Biologics, Chyn Boon Wong, Assistant Manager, Marketing and Scientific Affairs, Moringa Milk Industry, Jeremy Burton, Associate Professor, Western University, John Kirby, Professor and Chair, Department of Microbiology, Medical College of Wisconsin, Junrui Cheng, Senior Nutrition Scientist, Ingredion, Kera Nyemb-Diop, Lead Nutritionist, Fonterra, Mark Haupt, Chief Medical Officer, IFF, Miguel Freitas, Vice President - Scientific Affairs, Danone, Nini Fan, Chief Executive Officer, MaMome, Noah Zimmerman, Chief Technology Officer, Verb Biotics, Philip Strandwitz, Co-founder and Chief Executive Officer, Holobiome, Qingqi Lin, Lead Data Scientist, MaMome, Ruth Blanco, RDA Manager Clinical Studies CoE, Kerry Group, Shahram Lavasani, Chief Executive Officer, ImmuneBiome AB, Thomas Gurry, Chief Executive Officer, Myota Limited, Toby Amidor, President, Toby Amidor Nutrition, Vandana Sharma, Principal Nutrition Scientist, Pharmavite, Venkatakrishna Jala, Associate Professor, University of Louisville, Zack Abbott, Founder and Chief Executive Officer, ZBiotics